MedTrace Logo

Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence

NCT00385268 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-07-10

Study results available
· View outcomes & findings →

Summary

Trial to determine the safety, efficacy and tolerability of acamprosate for the treatment of cocaine dependence.

Conditions

  • Cocaine Dependence

Interventions

DRUG

acamprosate

1998 mg/dau fpr 8 weeks

DRUG

placebo

placebo pills

Sponsors & Collaborators

Principal Investigators

  • Helen Pettinati, Ph.D. · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-05-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00385268 on ClinicalTrials.gov